Charles Schwab Investment Management Inc Soleno Therapeutics Inc Transaction History

Charles Schwab Investment Management Inc

  • $515 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021
SELL
$0.97 - $1.32 $119,787 - $163,009
-123,492 Closed
0 $0
Q1 2021

May 17, 2021
SELL
$1.24 - $3.3 $42,711 - $113,668
-34,445 Reduced 21.81%
123,492 $156,000
Q3 2020

Nov 13, 2020
BUY
$1.71 - $2.51 $146,854 - $215,558
85,880 Added 119.18%
157,937 $397,000
Q2 2020

Aug 14, 2020
BUY
$1.77 - $4.23 $127,540 - $304,801
72,057 New
72,057 $160,000

About SOLENO THERAPEUTICS INC

SLNO Quotes by TradingView
  • Ticker SLNO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 8,101,250
  • Market Cap $375M
  • Description
  • Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead candidate is Diazoxide Choline Controlled-Release, a once-daily oral tablet for the treatment of Prader-Willi Syndrome, which is being evaluated in an ongoing P...
More about SLNO
Track This Portfolio

Track Charles Schwab Investment Management Inc Portfolio

Follow Charles Schwab Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email